Rational Selection and Application of Ready-to-Use Formulations for Self-Emulsifying Drug Delivery Systems

This webinar will discuss WuXi STA’s practice on overall RSM strategy, focusing on: Starting material evolution, RSM designation, Risk mitigation for potential regulatory push-back

The management of the United States’ massive prescription drug spend is plagued by inefficient, manual processes and errors which exact enormous human and financial tolls on society.

Using electronics today is a part of our daily lives. It is almost impossible to imagine how the world would be without electronics. The healthcare industry is not an exception to this. The drive towards having connected healthcare has become a well-established facet of current drug delivery device development, the overwhelming potential benefits has led to an explosion of development projects aiming to create connected device.

Pharmaceutical companies and their drugs face numerous challenges in the brief window between launch and patent expiration. This makes it extremely important to plan lifecycle management (LCM) strategies well in advance of patent expiry. One way to address this is with advanced manufacturing techniques that make it much more difficult for competitors to genericize. For pharmaceutical companies that seek market enhancement strategies beyond the capabilities of existing fast melt technologies, join Contract Pharma for this webinar as we hear from Don Wetherhold, the senior executive advisor and senior vice president of Aprecia Pharmaceuticals. He will talk about the company’s innovative ZipDose technology and why it offers an exclusive opportunity to address patient demand and create products not easily genericized.